NANDASI Pharma Advisors offers services in the CMC field (small molecules, peptides, oligonucleotides and conjugates) to biotech, CDMOs, big pharma and Investors. NANDASI Pharma Advisors acts as a discussion partner (second opinion) for CapEx investment, technology investment, portfolio review, due diligences of assets and for organizational changes in the CMC field. NANDASI Pharma Advisors offers an unbiased additional expertise to the executives of your company in a Scientific Advisory Board or Board of Directors.
Nandasi Pharma Advisors
